Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards - Jun 15, 2020
Continuous Glucose Monitoring (CGM) | FreeStyle Libre (CGM) systems
New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life - Oct 6, 2022
Intermittently Scanned CGM Reduced HbA1c in Type 1 Diabetes | MedPage Today
Novo levantamento mostra que o uso de FreeStyle Libre reduz significativamente níveis de HbA1c em pessoas com diabetes tipo 2
Abbott's FreeStyle® Libre 3 System Receives CE Mark - Features World's Smallest, Thinnest Sensor with Best-in-Class Performance at the Same Low Cost for People with Diabetes
Study shows reduced HbA1c with Abbott FreeStyle Libre 2 CGM
Large discrepancy between estimated A1c on Libreview vs Libre Link App | Diabetes Forum • The Global Diabetes Community
Real-World Data Show Patients With T2D Reducing A1C With FreeStyle Libre
Datos en vida real de FreeStyle Libre de Abbott muestran que ayuda a reducir los niveles de HbA1c
FreeStyle Libre reduces type 2 diabetes HbA1c levels - The Diabetes Times
Does retrospective continuous glucose monitoring improve HbA1c among adults with type 2 diabetes? – ACBRD
Study shows reduced HbA1c with Abbott FreeStyle Libre 2 CGM - Medical Buyer
Analysis backs Abbott's FreeStyle Libre CGM in diabetes | DDBN
Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies | SpringerLink
JCM | Free Full-Text | Metabolic Control of the FreeStyle Libre System in the Pediatric Population with Type 1 Diabetes Dependent on Sensor Adherence
Neueste Daten zeigen signifikante HbA1c-Senkung durch das FreeStyle Libre System von Abbott bei insulinpflichtigen und nicht-insulinpflichtigen Typ- 2-Diabetikern - Presse - alpha_z
